Chemical Structure : Bomedemstat
CAS No.: 1990504-34-1
Catalog No.: PC-20255Not For Human Use, Lab Use Only.
Bomedemstat (IMG-7289) is a potent, selective, irreversible and orally active LSD1 (KDM1A) inhibitor, increases H3K4 and H3K9 methylation.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $288 | In stock | |
10 mg | $468 | In stock | |
25 mg | Get quote | ||
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Bomedemstat (IMG-7289) is a potent, selective, irreversible and orally active LSD1 (KDM1A) inhibitor, increases H3K4 and H3K9 methylation.
Bomedemstat (IMG-7289) potentiated responses to PD-1 inhibition in a syngeneic model of SCLC, resulting in increased CD8+ T-cell infiltration and strong tumor growth inhibition.
Bomedemstat (IMG-7289) increased MHC class I expression in mouse SCLC tumor cells in vivo and augmented MHC-I induction by IFNγ and increased killing by tumor-specific T cells in cell culture.
Bomedemstat (IMG-7289) inhibits the production of inflammatory cytokines, impairs self-renewal and proliferation of neoplastic stem cells, and shows significant disease-modifying activities in multiple non-clinical models of myelofibrosis.
M.Wt | 519.63 | |
Formula | C28H34FN7O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-[(1S)-4-[[(1R,2S)-2-(4-Fluorophenyl)cyclopropyl]amino]-1-[(4-methyl-1-piperazinyl)carbonyl]butyl]-4-(1H-1,2,3-triazol-1-yl)benzamide |
1. Jutzi JS, et al. Hemasphere. 2018 Jun 8;2(3):e54.
2. Hiatt JB, et al. Clin Cancer Res. 2022 Oct 14;28(20):4551-4564.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright